Dietary antiaging phytochemicals and mechanisms associated with prolonged survival

Journal of Nutritional Biochemistry

Volumn 25, Issue 6, 2014, Pages 581-591

  Si, Hongwei ^a   Liu, Dongmin ^b  

^a TENNESSEE STATE UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Aging; Autophagy; Calorie restriction; Inflammation; Phytochemicals; Reactive oxygen species

Indexed keywords

ASCORBIC ACID; BETACYANIN; BETALAIN; BLUEBERRY EXTRACT; BUTEIN; COUMARIC ACID; CURCUMIN; EPICATECHIN; FISETIN; GARLIC EXTRACT; GLUCOSINOLATE; GLUTATHIONE DISULFIDE; GREEN TEA EXTRACT; INDOLE DERIVATIVE; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LUTEOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; ORGANOSULFUR DERIVATIVE; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; QUASSINOID; QUERCETIN; RESVERATROL; SUPEROXIDE DISMUTASE; TERPENE DERIVATIVE; TRITERPENOID; TROLOX C; UNINDEXED DRUG; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACNE; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTHRITIS; AUTOPHAGY; BIOLOGICAL FUNCTIONS; BLOOD VESSEL FUNCTION; CACAO; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COGNITION; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DYSENTERY; ENERGY METABOLISM; ENERGY YIELD; ENVIRONMENTAL FACTOR; EXERCISE; EYE INFECTION; FLATULENCE; GRAPE; HEART DISEASE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESPAN; LIFESTYLE; LONGEVITY; METABOLISM; MOTOR COORDINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOPOROSIS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHENOTYPE; REVIEW; SPRAIN; SURVIVAL; TEA; ULCER; ANIMAL; DIET; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH PROMOTION;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; AUTOPHAGY; CALORIC RESTRICTION; DIET; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HEALTH PROMOTION; HUMANS; LONGEVITY; NUTRITION POLICY; PHYTOCHEMICALS;

EID: 84899912154     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.02.001     Document Type: Review

References (209)

1. Ishizu T., Kajitani S., Tsutsumi H., Yamamoto H., Harano K. Diastereomeric difference of inclusion modes between (-)-epicatechin gallate, (-)-epigallocatechin gallate and (+)-gallocatechin gallate, with beta-cyclodextrin in aqueous solvent. Magn Reson Chem 2008, 46:448-456.
2. Heininger K. A unifying hypothesis of Alzheimer's disease. III. Risk factors. Hum Psychopharmacol 2000, 15:1-70.
3. Heininger K. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. Rev Neurosci 2000, 11 Spec No:213-328.
4. Frisard M., Ravussin E. Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine 2006, 29:27-32.
5. Ovaskainen M.L., Torronen R., Koponen J.M., Sinkko H., Hellstrom J., Reinivuo H., et al. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 2008, 138:562-566.
6. Higdon Jane, Drake V.J. An evidence-based approach to phytochemicals and other dietary factors 2013, Thieme, New York, [Chapter 8-19]. 2nd ed.
7. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
8. Wang Y., Chan F.L., Chen S., Leung L.K. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 2005, 77:39-51.
9. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
10. Zou S., Sinclair J., Wilson M.A., Carey J.R., Liedo P., Oropeza A., et al. Comparative approaches to facilitate the discovery of prolongevity interventions: effects of tocopherols on lifespan of three invertebrate species. Mech Ageing Dev 2007, 128:222-226.
11. Kiecolt-Glaser J.K., Epel E.S., Belury M.A., Andridge R., Lin J., Glaser R., et al. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav Immun 2012, 28:16-24.
12. Miller P.E., Snyder D.C. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract 2012, 27:599-612.
13. McCann S.E., Freudenheim J.L., Marshall J.R., Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003, 133:1937-1942.
14. Vasanthi H.R., ShriShriMal N., Das D.K. Phytochemicals from plants to combat cardiovascular disease. Curr Med Chem 2012, 19:2242-2251.
15. Bohn S.K., Ward N.C., Hodgson J.M., Croft K.D. Effects of tea and coffee on cardiovascular disease risk. Food Funct 2012, 3:575-591.
16. Gonzalez-Castejon M., Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obesity: a review. Pharmacol Res 2011, 64:438-455.
17. Yun J.W. Possible anti-obesity therapeutics from nature-a review. Phytochemistry 2010, 71:1625-1641.
18. Sears B., Ricordi C. Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes. Eur Rev Med Pharmacol Sci 2012, 16:1137-1154.
19. Youdim K.A., Joseph J.A. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 2001, 30:583-594.
20. Gu X.L., Creasy L., Kester A., Zeece M. Capillary electrophoretic determination of resveratrol in wines. J Agricult Food Chem 1999, 47:3223-3227.
21. Wang K.H., Lai Y.H., Chang J.C., Ko T.F., Shyu S.L., Chiou R.Y.Y. Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable. J Agricult Food Chem 2005, 53:242-246.
22. Ector B.J., Magee J.B., Hegwood C.P., Coign M.J. Resveratrol concentration in muscadine berries, juice, pomace, purees, seeds, and wines. Am J Enol Viticult 1996, 47:57-62.
23. Hurst W.J., Glinski J.A., Miller K.B., Apgar J., Davey M.H., Stuart D.A. Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products. J Agricult Food Chem 2008, 56:8374-8378.
24. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493-506.
25. Stervbo U., Vang O., Bonnesen C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 2007, 101:449-457.
26. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341:1103-1104.
27. Jang M.S., Cai E.N., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
28. Smoliga J.M., Baur J.A., Hausenblas H.A. Resveratrol and health-a comprehensive review of human clinical trials. Mol Nutr Food Res 2011, 55:1129-1141.
29. Gruber J., Tang S.Y., Halliwell B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann N Y Acad Sci 2007, 1100:530-542.
30. Bauer J.H., Goupil S., Garber G.B., Helfand S.L. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc Natl Acad Sci U S A 2004, 101:12980-12985.
31. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006, 16:296-300.
32. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
33. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008, 8:157-168.
34. Miller R.A., Harrison D.E., Astle C.M., Baur J.A., Boyd A.R., de Cabo R., et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011, 66:191-201.
35. Strong R., Miller R.A., Astle C.M., Baur J.A., de Cabo R., Fernandez E., et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2012, 68:6-16.
36. Ghanim H., Sia C.L., Abuaysheh S., Korzeniewski K., Patnaik P., Marumganti A., et al. An antiinflammatory and reactive oxygen species suppressive effects of an extract of polygonum cuspidatum containing resveratrol. J Clin Endocr Metab 2010, 95:E1-E8.
37. Brasnyo P., Molnar G.A., Mohas M., Marko L., Laczy B., Cseh J., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Brit J Nutr 2011, 106:383-389.
38. Wong R.H.X., Howe P.R.C., Buckley J.D., Coates A.M., Kunz I., Berry N.M. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovas 2011, 21:851-856.
39. Kennedy D.O., Wightman E.L., Reay J.L., Lietz G., Okello E.J., Wilde A., et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010, 91:1590-1597.
40. clinicaltrials.gov: Resveratrol and health in clinic trials. In.: ; 2013. http://clinicaltrials.gov/ct2/results?term=resveratrol&Search=Search.
41. Kim H., Keeney P.G. (-)-Epicatechin content in fermented and unfermented cocoa beans. J Food Sci 1984, 49:1090-1092.
42. Arts I.C.W., van de Putte B., Hollman P.C.H. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agricult Food Chem 2000, 48:1746-1751.
43. Arts I.C.W., van de Putte B., Hollman P.C.H. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agricult Food Chem 2000, 48:1752-1757.
44. Bayard V., Chamorro F., Motta J. Hollenberg Nk. Does flavanol intake influence mortality from nitrix oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci 2007, 4:53-58.
45. Hollenberg N.K., Martinez G., McCullough M., Meinking T., Passan D., Preston M., et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 1997, 29:171-176.
46. Hollenberg N.K. Naomi. F. Is it the dark in dark chocolate?. Circulation 2007, 116:2360-2362.
47. Kirschbaum J. Effect on human longevity of added dietary chocolate. Nutrition 1998, 14:869.
48. Ding E.L., Hutfless S.M., Ding X., Girotra S. Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond) 2006, 3:2. 10.1186/1743-7075-3-2.
49. Heiss C., Dejam A., Kleinbongard P., Schewe T., Sies H., Kelm M. Vascular effects of cocoa rich in flavan-3-ols. Jama 2003, 290:1030-1031.
50. Balzer J., Rassaf T., Heiss C., Kleinbongard P., Lauer T., Merx M., et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardi 2008, 51:2141-2149.
51. Bisson J.F., Nejdi A., Rozan P., Hidalgo S., Lalonde R., Messaoudi M. Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats. Brit J Nutr 2008, 100:94-101.
52. Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C.L., Hollenberg N.K., et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006, 103:1024-1029.
53. Holt R.R., Actis-Goretta L., Momma T.Y., Keen C.L. Dietary flavanols and platelet reactivity. J Cardiovasc Pharmacol 2006, 47(Suppl. 2):S187-S196. discussion S206-9.
54. Si H, Fu Z, Babu PV, Zhen W, Leroith T, Meaney MP et al. Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster. J Nutr; 141:1095-100.
55. Sunagawa T., Shimizu T., Kanda T., Tagashira M., Sami M., Shirasawa T. Procyanidins from apples (Malus pumila mill.) extend the lifespan of caenorhabditis elegans. Planta Med 2011, 77:122-127.
56. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81:243S-255S.
57. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
58. Pietsch K., Saul N., Menzel R., Sturzenbaum S.R., Steinberg C.E. Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43. Biogerontology 2009, 10:565-578.
59. Saul N., Pietsch K., Menzel R., Steinberg C.E. Quercetin-mediated longevity in Caenorhabditis elegans: is DAF-16 involved?. Mech Ageing Dev 2008, 129:611-613.
60. Chondrogianni N., Kapeta S., Chinou I., Vassilatou K., Papassideri I., Gonos E.S. Anti-ageing and rejuvenating effects of quercetin. Exp Gerontol 2010, 45:763-771.
61. Arts M.J.T.J., Dallinga J.S., Voss H.P., Haenen G.R.M.M., Bast A. A new approach to assess the total antioxidant capacity using the TEAC assay. Food Chem 2004, 88:567-570.
62. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008, 585:325-337.
63. Vanacker S.A.B.E., Tromp M.N.J.L., Haenen G.R.M.M., Vandervijgh W.J.F., Bast A. Flavonoids as scavengers of nitric-oxide radical. Biochem Bioph Res Co 1995, 214:755-759.
64. Bureau G., Longpre F., Martinoli M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 2008, 86:403-410.
65. Manjeet K.R., Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int J Immunopharmacol 1999, 21:435-443.
66. Itokawa H., Shi Q., Akiyama T., Morris-Natschke S.L., Lee K.H. Recent advances in the investigation of curcuminoids. Chin Med 2008, 3:11.
67. Ammon H.P., Wahl M.A. Pharmacology of curcuma longa. Planta Med 1991, 57:1-7.
68. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995, 94:79-83.
69. Singh A.K., Jiang Y., Benlhabib E., Gupta S. Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water. J Med Food 2007, 10:526-542.
70. Shen L.R., Xiao F., Yuan P., Chen Y., Gao Q.K., Parnell L.D., et al. Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordr) 2013, 35:1133-1142.
71. Soh J.W., Marowsky N., Nichols T.J., Rahman A.M., Miah T., Sarao P., et al. Curcumin is an early-acting stage-specific inducer of extended functional longevity in Drosophila. Exp Gerontol 2013, 48:229-239.
72. Lee K.S., Lee B.S., Semnani S., Avanesian A., Um C.Y., Jeon H.J., et al. Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Res 2010, 13:561-570.
73. Liao V.H., Yu C.W., Chu Y.J., Li W.H., Hsieh Y.C., Wang T.T. Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech Ageing Dev 2011, 132:480-487.
74. Kitani K., Osawa T., Yokozawa T. The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice. Biogerontology 2007, 8:567-573.
75. Banji D., Banji O.J., Dasaroju S., Annamalai A.R. Piperine and curcumin exhibit synergism in attenuating d-galactose induced senescence in rats. Eur J Pharmacol 2013, 703:91-99.
76. Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006, 30:45-51.
77. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
78. Barzegar A., Moosavi-Movahedi A.A. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. Plos One 2011, 6:e26012-e26019.
79. Basu A., Lucas E.A. Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 2007, 65:361-375.
80. Davalli P., Rizzi F., Caporali A., Pellacani D., Davoli S., Bettuzzi S., et al. Anticancer activity of green tea polyphenols in prostate gland. Oxid Med Cell Longev 2012, 10.1155/2012/984219.
81. Thielecke F., Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review. Phytochemistry 2009, 70:11-24.
82. Sae-tan S., Grove K.A., Lambert J.D. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 2011, 64:146-154.
83. Li Q., Li Y. Review on the neuroprotective effects of green tea polyphenols for the treatment of neurodegenerative diseases. Wei Sheng Yan Jiu 2010, 39:123-126.
84. Li Y.M., Chan H.Y.E., Yao X.Q., Huang Y., Chen Z.Y. Green tea catechins and broccoli reduce fat-induced mortality in Drosophila melanogaster. J Nutr Biochem 2008, 19:376-383.
85. Abbas S., Wink M. Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans. Planta Med 2009, 75:216-221.
86. Zhang L.Z., Jie G.L., Zhang J.J., Zhao B.L. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress. Free Radical Biol Med 2009, 46:414-421.
87. Aires D.J., Rockwell G., Wang T., Frontera J., Wick J., Wang W.F., et al. Potentiation of dietary restriction-induced lifespan extension by polyphenols. BBA-Mol Basis Dis 1822, 2012:522-526.
88. Sadakata S., Fukao A., Hisamichi S. Mortality among female practitioners of Chanoyu. Tohoku J Exp Med 1992, 166:3.
89. Moriguchi T., Saito H., Nishiyama N. Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model. Clin Exp Pharmacol Physiol 1997, 24:235-242.
90. Xiang L., Sun K.Y., Lu J., Weng Y.F., Taoka A., Sakagami Y., Qi J.H. Anti-aging effects of phloridzin, an apple polyphenol, on yeast via the SOD and Sir2 genes. Biosci Biotech Bioch 2011, 75:854-858.
91. Kampkotter A., Nkwonkam C.G., Zurawski R.F., Timpel C., Chovolou Y., Watjen W., et al. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Arch Toxicol 2007, 81:849-858.
92. Zarse K., Bossecker A., Muller-Kuhrt L., Siems K., Hernandez M.A., Berendsohn W.G., et al. The phytochemical glaucarubinone promotes mitochondrial metabolism, reduces body fat, and extends lifespan of Caenorhabditis elegans. Horm Metab Res 2011, 43:241-243.
93. Wilson M.A., Shukitt-Hale B., Kalt W., Ingram D.K., Joseph J.A., Wolkow C.A. Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 2006, 5:59-68.
94. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979, 59:527-605.
95. Harman D. The biologic clock: the mitochondria?. J Am Geriatr Soc 1972, 20:145-147.
96. Linnane A.W., Marzuki S., Ozawa T., Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1:642-645.
97. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
98. Chang T.S., Cho C.S., Park S., Yu S., Kang S.W., Rhee S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 2004, 279:41975-41984.
99. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 1994, 91:10771-10778.
100. Sohal R.S., Sohal B.H. Hydrogen peroxide release by mitochondria increases during aging. Mech Ageing Dev 1991, 57:187-202.
101. Asensi M., Sastre J., Pallardo F.V., Lloret A., Lehner M., Garcia-de-la Asuncion J., et al. Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol 1999, 299:267-276.
102. Nenadis N., Wang L.F., Tsimidou M., Zhang H.Y. Estimation of scavenging activity of phenolic compounds using the ABTS(*+) assay. J Agric Food Chem 2004, 52:4669-4674.
103. Lu M., Cai Y.J., Fang J.G., Zhou Y.L., Liu Z.L., Wu L.M. Efficiency and structure-activity relationship of the antioxidant action of resveratrol and its analogs. Pharmazie 2002, 57:474-478.
104. Yokozawa T., Chen C.P., Dong E., Tanaka T., Nonaka G.I., Nishioka I. Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2 picrylhydrazyl radical. Biochem Pharmacol 1998, 56:213-222.
105. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997, 22:749-760.
106. Wolfe K.L., Liu R.H. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay. J Agric Food Chem 2008, 56:8404-8411.
107. Modak B., Contreras M.L., Gonzalez-Nilo F., Torres R. Structure-antioxidant activity relationships of flavonoids isolated from the resinous exudate of Heliotropium sinuatum. Bioorg Med Chem Lett 2005, 15:309-312.
108. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004, 101:3381-3386.
109. Shih P.H., Yen G.C. Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 2007, 8:71-80.
110. Asha Devi S., Prathima S., Subramanyam M.V. Dietary vitamin E and physical exercise: II. Antioxidant status and lipofuscin-like substances in aging rat heart. Exp Gerontol 2003, 38:291-297.
111. Unlu E.S., Koc A. Effects of deleting mitochondrial antioxidant genes on life span. Ann N Y Acad Sci 2007, 1100:505-509.
112. Phillips J.P., Campbell S.D., Michaud D., Charbonneau M., Hilliker A.J. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci U S A 1989, 86:2761-2765.
113. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24:367-380.
114. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 1996, 93:9782-9787.
115. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M.H., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
116. Singh S., Das Roy L., Giri S. Curcumin protects metronidazole and X-ray induced cytotoxicity and oxidative stress in male germ cells in mice. Prague Med Rep 2013, 114:92-102.
117. Kesherwani V., Atif F., Yousuf S., Agrawal S.K. Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience 2013, 241:80-88.
118. Roy S., Sannigrahi S., Vaddepalli R.P., Ghosh B., Pusp P. A novel combination of methotrexate and epigallocatechin attenuates the overexpression of pro-inflammatory cartilage cytokines and modulates antioxidant status in adjuvant arthritic rats. Inflammation 2012, 35:1435-1447.
119. Uygur R., Yagmurca M., Alkoc O.A., Genc A., Songur A., Ucok K., et al. Effects of quercetin and fish n-3 fatty acids on testicular injury induced by ethanol in rats. Andrologia 2013, 10.1111/and.12085.
120. Itoh K., Tong K.I., Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 2004, 36:1208-1213.
121. Kobayashi M., Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005, 7:385-394.
122. Khor T.O., Huang M.T., Prawan A., Liu Y., Hao X., Yu S., et al. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res (Phila) 2008, 1:187-191.
123. Son T.G., Camandola S., Mattson M.P. Hormetic dietary phytochemicals. Neuromolecular Med 2008, 10:236-246.
124. Ma Q., He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 2012, 64:1055-1081.
125. Vauzour D., Buonfiglio M., Corona G., Chirafisi J., Vafeiadou K., Angeloni C., et al. Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol Nutr Food Res 2010, 54:532-542.
126. Yu R., Lei W., Mandlekar S., Weber M.J., Der C.J., Wu J., et al. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem 1999, 274:27545-27552.
127. Wu C.C., Hsu M.C., Hsieh C.W., Lin J.B., Lai P.H., Wung B.S. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006, 78:2889-2897.
128. Wruck C.J., Claussen M., Fuhrmann G., Romer L., Schulz A., Pufe T., et al. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 2007, 72:57-67.
129. Rushworth S.A., Ogborne R.M., Charalambos C.A., O'Connell M.A. Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 2006, 341:1007-1016.
130. Jeong W.S., Keum Y.S., Chen C., Jain M.R., Shen G., Kim J.H., et al. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol 2005, 38:167-176.
131. Apfeld J., O'Connor G., McDonagh T., DiStefano P.S., Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 2004, 18:3004-3009.
132. Kumar A., Singh C.K., Lavoie H.A., Dipette D.J., Singh U.S. Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Mol Pharmacol 2011, 80:446-457.
133. Shah Z.A., Li R.C., Ahmad A.S., Kensler T.W., Yamamoto M., Biswal S., et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 2010, 30:1951-1961.
134. Granado-Serrano A.B., Martin M.A., Haegeman G., Goya L., Bravo L., Ramos S. Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br J Nutr 2010, 103:168-179.
135. Si H., Liu D. Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 2008, 138:297-304.
136. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol Rev 2009, 89:1025-1078.
137. Bergeron R., Previs S.F., Cline G.W., Perret P., Russell R.R., Young L.H., et al. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 2001, 50:1076-1082.
138. Jorgensen S.B., Wojtaszewski J.F., Viollet B., Andreelli F., Birk J.B., Hellsten Y., et al. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 2005, 19:1146-1148.
139. Carling D., Sanders M.J., Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 2008, 32(Suppl 4):S55-S59.
140. Witczak C.A., Sharoff C.G., Goodyear L.J. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 2008, 65:3737-3755.
141. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 2007, 104:12017-12022.
142. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
143. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
144. Greer E.L., Banko M.R., Brunet A. AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Ann N Y Acad Sci 2009, 1170:688-692.
145. Ruderman N.B., Xu X.J., Nelson L., Cacicedo J.M., Saha A.K., Lan F., et al. AMPK and SIRT1: a long-standing partnership?. Am J Physiol Endocrinol Metab 2010, 298:E751-E760.
146. Fisslthaler B., Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Cir Res 2009, 105:114-127.
147. Nagata D., Hirata Y. The role of AMP-activated protein kinase in the cardiovascular system. Hypertens Res 2010, 33:22-28.
148. Qiang W., Weiqiang K., Qing Z., Pengju Z., Yi L. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp Mol Med 2007, 39:535-543.
149. Reznick R.M., Zong H., Li J., Morino K., Moore I.K., Yu H.J., et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 2007, 5:151-156.
150. Dong Y., Zhang M., Liang B., Xie Z., Zhao Z., Asfa S., et al. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 2010, 121:792-803.
151. You M., Matsumoto M., Pacold C.M., Cho W.K., Crabb D.W. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 2004, 127:1798-1808.
152. Ajmo J.M., Liang X., Rogers C.Q., Pennock B., You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008, 295:G833-G842.
153. Porquet D., Casadesus G., Bayod S., Vicente A., Canudas A.M., Vilaplana J., et al. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age (Dordr) 2013, 35:1851-1865.
154. Kim M.Y., Lim J.H., Youn H.H., Hong Y.A., Yang K.S., Park H.S., et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice. Diabetologia 2013, 56:204-217.
155. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
156. Nieman D.C., Williams A.S., Shanely R.A., Jin F., McAnulty S.R., Triplett N.T., et al. Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med Sci Sports Exerc 2010, 42:338-345.
157. Davis J.M., Murphy E.A., Carmichael M.D., Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1071-R1077.
158. Ye Q., Ye L., Xu X., Huang B., Zhang X., Zhu Y., Chen X. Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway. BMC Complement Altern Med 2012, 10.1186/1472-6882-12-82.
159. Kim T., Davis J., Zhang A.J., He X., Mathews S.T. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009, 388:377-382.
160. Soetikno V., Sari F.R., Sukumaran V., Lakshmanan A.P., Harima M., Suzuki K., et al. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. J Nutr Biochem 2013, 24:796-802.
161. Gasser S.M., Cockell M.M. The molecular biology of the SIR proteins. Gene 2001, 279:1-16.
162. Lin S.J., Defossez P.A., Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000, 289:2126-2128.
163. Rogina B., Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 2004, 101:15998-16003.
164. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
165. Jeong J., Juhn K., Lee H., Kim S.H., Min B.H., Lee K.M., et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 2007, 39:8-13.
166. Langley E., Pearson M., Faretta M., Bauer U.M., Frye R.A., Minucci S., et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002, 21:2383-2396.
167. Zu Y., Liu L., Lee M.Y., Xu C., Liang Y., Man R.Y., et al. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 2010, 106:1384-1393.
168. Zhang J. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J Biol Chem 2007, 282:34356-34364.
169. Bordone L., Motta M.C., Picard F., Robinson A., Jhala U.S., Apfeld J., et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006, 4:e31. 10.1371/journal.pbio.0040031.
170. Daitoku H., Hatta M., Matsuzaki H., Aratani S., Ohshima T., Miyagishi M., et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A 2004, 101:10042-10047.
171. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
172. Price N.L., Gomes A.P., Ling A.J., Duarte F.V., Martin-Montalvo A., North B.J., et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 2012, 15:675-690.
173. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
174. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 2009, 74:619-624.
175. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010, 285:8340-8351.
176. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
177. de Boer V.C., de Goffau M.C., Arts I.C., Hollman P.C., Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev 2006, 127:618-627.
178. Choi K.C., Jung M.G., Lee Y.H., Yoon J.C., Kwon S.H., Kang H.B., et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009, 69:583-592.
179. Feng Y., Wu J., Chen L., Luo C., Shen X., Chen K., et al. A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide. Anal Biochem 2009, 395:205-210.
180. Berryman D.E., Christiansen J.S., Johannsson G., Thorner M.O., Kopchick J.J. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res 2008, 18:455-471.
181. Bartke A., Peluso M.R., Moretz N., Wright C., Bonkowski M., Winters T.A., et al. Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm Metab Res 2004, 36:550-558.
182. Barzilai N., Huffman D.M., Muzumdar R.H., Bartke A. The critical role of metabolic pathways in aging. Diabetes 2012, 61:1315-1322.
183. Holzenberger M. The GH/IGF-I axis and longevity. Eur J Endocrinol 2004, 151(Suppl 1):S23-S27.
184. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003, 13:113-170.
185. Janssen J.A., Lamberts S.W. Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?. J Endocrinol Invest 1999, 22:313-315.
186. Ning J., Clemmons D.R. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Mol Endocrinol 2010, 24:1218-1229.
187. Youreva V., Kapakos G., Srivastava A.K. Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells. Can J Physiol Pharmacol 2013, 91:241-247.
188. Vanamala J., Reddivari L., Radhakrishnan S., Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 2010, 10.1186/1471-2407-10-238.
189. Shimizu M., Shirakami Y., Sakai H., Tatebe H., Nakagawa T., Hara Y., et al. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett 2008, 262:10-18.
190. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
191. Brod S.A. Unregulated inflammation shortens human functional longevity. Inflamm Res 2000, 49:561-570.
192. Traish A.M., Kang H.P., Saad F., Guay A.T. Dehydroepiandrosterone (DHEA)-a precursor steroid or an active hormone in human physiology. J Sex Med 2011, 8:2960-2982. [quiz 83].
193. Franceschi C., Bonafe M., Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000, 18:1717-1720.
194. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., et al. The immune system in extreme longevity. Exp Gerontol 2008, 43:61-65.
195. Chung H.Y., Sung B., Jung K.J., Zou Y., Yu B.P. The molecular inflammatory process in aging. Antioxid Redox Signal 2006, 8:572-581.
196. Zou Y., Jung K.J., Kim J.W., Yu B.P., Chung H.Y. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004, 18:320-322.
197. Bisht K., Wagner K.H., Bulmer A.C. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 2010, 278:88-100.
198. Babu P.V.A., Si H.W., Liu D.M. Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-kappa B-mediated mechanism. Mol Nutr Food Res 2012, 56:1424-1432.
199. Indra M.R., Karyono S., Ratnawati R., Malik S.G. Quercetin suppresses inflammation by reducing ERK1/2 phosphorylation and NF kappa B activation in Leptin-induced Human Umbilical Vein Endothelial Cells (HUVECs). BMC Res Notes 2013, 6:275. 10.1186/1756-0500-6-275.
200. Cuervo A.M. Autophagy and aging: keeping that old broom working. Trends Genet 2008, 24:604-612.
201. Hansen M., Chandra A., Mitic L.L., Onken B., Driscoll M., Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C elegans. PLoS Genet 2008, 4:e24. 10.1371/journal.pgen.0040024.
202. Del Roso A., Vittorini S., Cavallini G., Donati A., Gori Z., Masini M., et al. Ageing-related changes in the in vivo function of rat liver macroautophagy and proteolysis. Exp Gerontol 2003, 38:519-527.
203. Ghosh H.S., McBurney M., Robbins P.D. SIRT1 negatively regulates the mammalian target of rapamycin. Plos One 2010, 5:e9199. 10.1371/journal.pone.0009199.
204. Roy S.K., Chen Q.H., Fu J.S., Shankar S., Srivastava R.K. Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors. Plos One 2011, 6:e25166. 10.1371/journal.pone.0025166.
205. Devika P.T., Prince P.S. Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats. Chem Biol Interact 2008, 172:245-252.
206. Arlorio M., Bottini C., Travaglia F., Locatelli M., Bordiga M., Coisson J.D., et al. Protective Activity of Theobroma cacao L. Phenolic Extract on AML12 and MLP29 Liver Cells by Preventing Apoptosis and Inducing Autophagy. J Agricult Food Chem 2009, 57:10612-10618.
207. Klappan A.K., Hones S., Mylonas I., Bruning A. Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity. Histochem Cell Biol 2012, 137:25-36.
208. Alavez S., Vantipalli M.C., Zucker D.J.S., Klang I.M., Lithgow G.J. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 2011, 472:226-229.
209. Wu J.C., Lai C.S., Badmaev V., Nagabhushanam K., Ho C.T., Pan M.H. Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Molecular Nutr Food Res 2011, 55:1646-1654.